Immunogenicity Negatively Influences the Outcome of Adalimumab Treatment in Crohn’s Disease
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/j.1365-2036.2008.03828.x
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2008
Authors
Publisher
Wiley